{"title":"Multienzymatic Hybrid Metalloenzymes Triggering Cascade Reactions-Regulated Tumor Redox Homeostasis and Immunosuppressive Microenvironment for Catalytic Immunotherapy.","authors":"Wanying Sun, Juan Song, Chengyuan Zhu, Xiaolu Guo, Bang-Ping Jiang, Cunji Gao, Xing-Can Shen","doi":"10.1021/acsnano.5c06592","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial multienzyme systems hold promise for tumor catalytic immunotherapy by a cascade catalyzing the generation of reactive oxygen species (ROS). However, the intricate redox homeostasis restricts ROS accumulation coupled with the immunosuppressive tumor microenvironment (TME), resulting in unsatisfactory therapeutic efficacy. Developing multienzyme systems that can overcome multifaceted TME limitations for effective catalytic immunotherapy is still a significant challenge. Inspired by natural metalloenzymes, herein, a synergistic multienzyme nanoplatform (Co<sub>3</sub>S<sub>4</sub>@LOx/HA) is constructed by integrating mixed-valent cobalt sulfide (Co<sub>3</sub>S<sub>4</sub>) nanozymes as artificial cofactors and lactate oxidase (LOx) as protein scaffolds, encapsulated with hyaluronic acid (HA). Through self-cyclic cascade catalysis involving multienzyme activities (LOx, catalase-like, peroxidase-like, and glutathione peroxidase-like activities), Co<sub>3</sub>S<sub>4</sub>@LOx/HA can concurrently facilitate H<sub>2</sub>O<sub>2</sub> and <sup>•</sup>OH generation and deplete intracellular glutathione (GSH). Moreover, Co<sub>3</sub>S<sub>4</sub>@LOx/HA can also inhibit endogenous thioredoxin reductase (TrxR) activity by the acidic TME-responsive release of hydrogen sulfide (H<sub>2</sub>S), further disrupting intracellular redox homeostasis. As a result, the significantly amplified ROS increased double-stranded DNA damage and leakage, thereby activating the stimulator of interferon genes (STING)-related immune responses. Additionally, lactate consumption and O<sub>2</sub> generation during catalytic processes remodeled the immunosuppressive TME. Overall, Co<sub>3</sub>S<sub>4</sub>@LOx/HA is the first multienzyme nanoplatform that can simultaneously modulate multiple redox homeostasis and the immunosuppressive TME for precise and efficient tumor catalytic immunotherapy. This biomimetic metalloenzyme strategy will inspire more innovative designs of multienzyme nanoplatforms for ROS-mediated tumor therapies.</p>","PeriodicalId":21,"journal":{"name":"ACS Nano","volume":" ","pages":"24034-24051"},"PeriodicalIF":16.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Nano","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1021/acsnano.5c06592","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Artificial multienzyme systems hold promise for tumor catalytic immunotherapy by a cascade catalyzing the generation of reactive oxygen species (ROS). However, the intricate redox homeostasis restricts ROS accumulation coupled with the immunosuppressive tumor microenvironment (TME), resulting in unsatisfactory therapeutic efficacy. Developing multienzyme systems that can overcome multifaceted TME limitations for effective catalytic immunotherapy is still a significant challenge. Inspired by natural metalloenzymes, herein, a synergistic multienzyme nanoplatform (Co3S4@LOx/HA) is constructed by integrating mixed-valent cobalt sulfide (Co3S4) nanozymes as artificial cofactors and lactate oxidase (LOx) as protein scaffolds, encapsulated with hyaluronic acid (HA). Through self-cyclic cascade catalysis involving multienzyme activities (LOx, catalase-like, peroxidase-like, and glutathione peroxidase-like activities), Co3S4@LOx/HA can concurrently facilitate H2O2 and •OH generation and deplete intracellular glutathione (GSH). Moreover, Co3S4@LOx/HA can also inhibit endogenous thioredoxin reductase (TrxR) activity by the acidic TME-responsive release of hydrogen sulfide (H2S), further disrupting intracellular redox homeostasis. As a result, the significantly amplified ROS increased double-stranded DNA damage and leakage, thereby activating the stimulator of interferon genes (STING)-related immune responses. Additionally, lactate consumption and O2 generation during catalytic processes remodeled the immunosuppressive TME. Overall, Co3S4@LOx/HA is the first multienzyme nanoplatform that can simultaneously modulate multiple redox homeostasis and the immunosuppressive TME for precise and efficient tumor catalytic immunotherapy. This biomimetic metalloenzyme strategy will inspire more innovative designs of multienzyme nanoplatforms for ROS-mediated tumor therapies.
期刊介绍:
ACS Nano, published monthly, serves as an international forum for comprehensive articles on nanoscience and nanotechnology research at the intersections of chemistry, biology, materials science, physics, and engineering. The journal fosters communication among scientists in these communities, facilitating collaboration, new research opportunities, and advancements through discoveries. ACS Nano covers synthesis, assembly, characterization, theory, and simulation of nanostructures, nanobiotechnology, nanofabrication, methods and tools for nanoscience and nanotechnology, and self- and directed-assembly. Alongside original research articles, it offers thorough reviews, perspectives on cutting-edge research, and discussions envisioning the future of nanoscience and nanotechnology.